VERDE BIO HOLDINGS, INC. - Form 8-K SEC filing

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act Of 1934

Date of Report (Date of earliest event reported): August 25, 2022

VERDE BIO HOLDINGS, INC.

(Exact Name of Registrant as Specified in Charter)


Nevada	000-54524	30-0678378
(State or Other Jurisdiction of Incorporation)	(Commission File Number)	(IRS Employer Identification No.)

5750 Genesis Court, Suite 220

Frisco, Texas 75034

(Address of Principal Executive Offices)

(972) 217-4080

(Registrant’s Telephone Number, Including Area Code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐		Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐		Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐		Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐		Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 1.01 Entry into a Material Definitive Agreement

On August 24, 2022, Verde Bio Holdings, Inc. (the “Company”) announced that it had entered into an Amendment (“Amendment”) to the Securities Purchase Agreement (“Purchase Agreement”) with GHS Investments LLC (“GHS”). The Amendment amends Section 3.1(dd) to correct the date of the Company’s fiscal year end and Schedule 3.1(dd) to name the Company’s “accounting firm” as Sadler, Gibb & Associates LLC.

A form of the Amendment is filed as Exhibit 10.1 to this Current Report on Form 8-K.

Item 9.01

Financial Statements and Exhibits.

Exhibits. The following exhibits are being filed herewith:

Exhibit Number		Description of Exhibits
10.1		Amendment to Securities Purchase Agreement dated August 25, 2022.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, hereunto duly authorized, on the 25th day of August, 2022.

VERDE BIO HOLDINGS, INC.
By:	/s/ Scott A. Cox
	Name:	Scott A. Cox
	Title:	Chief Executive Officer